Provided by Tiger Fintech (Singapore) Pte. Ltd.

4D Molecular Therapeutics

2.76
+0.25009.96%
Post-market: 2.850.0900+3.26%19:58 EDT
Volume:1.77M
Turnover:4.53M
Market Cap:127.79M
PE:-0.93
High:2.90
Open:2.45
Low:2.24
Close:2.51
Loading ...
May 04, 2023

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 15, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2023

Major Issues Report

8-K - Current report
Mar 15, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2023

Major Issues Report

8-K - Current report
Jan 26, 2023

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 27, 2022

Major Issues Report

8-K - Current report
Sep 01, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Major Issues Report

8-K - Current report
Jun 21, 2022

Major Issues Report

8-K - Current report
Jun 21, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 27, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]